Neurotrack, a Redwood City, California-based creator of a digital memory health platform, raised $13.7m in Series B funding.
The round was led by Sozo Ventures with participation from Marc Benioff, Khosla Ventures, Founders Fund, Social Capital, AME Cloud Partners and Rethink Impact.
Led by co-founder and CEO Elli Kaplan, Neurotrack is building a digital memory health platform, giving people direct access to digital tools and technology to understand, manage and track their brain health.
Based on 30 years of scientific research, the company’s platform allows people to assess their memory through proprietary Imprint TM cognitive assessment, and manage memory loss and cognitive decline with the help of a digital therapeutic platform.
The company intends to use the funds to continue to develop its platform, which includes the Imprint cognitive assessment and the forthcoming memory health program, based on large, randomized controlled scientific studies, such as the FINGER and MIND diet studies.
Scientific co-founders Stuart Zola, Ph.D., Elizabeth Buffalo, Ph.D., and Cecelia Manzanares, along with a team led by Chief Science Officer Nick Bott, Psy.D., have developed Neurotrack’s digital health platform, based on 30 years of scientific research.